These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
836 related items for PubMed ID: 28094038
1. Triaging HPV-positive women with p16/Ki-67 dual-stained cytology: Results from a sub-study nested into the ATHENA trial. Wright TC, Behrens CM, Ranger-Moore J, Rehm S, Sharma A, Stoler MH, Ridder R. Gynecol Oncol; 2017 Jan; 144(1):51-56. PubMed ID: 28094038 [Abstract] [Full Text] [Related]
2. Triaging HPV-positive women with normal cytology by p16/Ki-67 dual-stained cytology testing: baseline and longitudinal data. Uijterwaal MH, Polman NJ, Witte BI, van Kemenade FJ, Rijkaart D, Berkhof J, Balfoort-van der Meij GA, Ridder R, Snijders PJ, Meijer CJ. Int J Cancer; 2015 May 15; 136(10):2361-8. PubMed ID: 25345358 [Abstract] [Full Text] [Related]
3. p16/Ki-67 dual-stained cytology for detecting cervical (pre)cancer in a HPV-positive gynecologic outpatient population. Luttmer R, Dijkstra MG, Snijders PJ, Berkhof J, van Kemenade FJ, Rozendaal L, Helmerhorst TJ, Verheijen RH, Ter Harmsel WA, van Baal WM, Graziosi PG, Quint WG, Spruijt JW, van Dijken DK, Heideman DA, Meijer CJ. Mod Pathol; 2016 Aug 15; 29(8):870-8. PubMed ID: 27150161 [Abstract] [Full Text] [Related]
4. Performance of HPV Genotyping Combined with p16/Ki-67 in Detection of Cervical Precancer and Cancer Among HPV-Positive Chinese Women. Jiang MY, Wu Z, Li T, Yu L, Zhang SK, Zhang X, Qu P, Sun P, Xi MR, Liu X, Liao G, Sun L, Zhang Y, Chen W, Qiao YL. Cancer Prev Res (Phila); 2020 Feb 15; 13(2):163-172. PubMed ID: 31871224 [Abstract] [Full Text] [Related]
5. Approaches to triage optimization in HPV primary screening: Extended genotyping and p16/Ki-67 dual-stained cytology-Retrospective insights from ATHENA. Stoler MH, Baker E, Boyle S, Aslam S, Ridder R, Huh WK, Wright TC. Int J Cancer; 2020 May 01; 146(9):2599-2607. PubMed ID: 31490545 [Abstract] [Full Text] [Related]
10. Performance of p16/Ki-67 immunostaining to detect cervical cancer precursors in a colposcopy referral population. Wentzensen N, Schwartz L, Zuna RE, Smith K, Mathews C, Gold MA, Allen RA, Zhang R, Dunn ST, Walker JL, Schiffman M. Clin Cancer Res; 2012 Aug 01; 18(15):4154-62. PubMed ID: 22675168 [Abstract] [Full Text] [Related]
11. Five-Year Risk of Cervical Precancer Following p16/Ki-67 Dual-Stain Triage of HPV-Positive Women. Clarke MA, Cheung LC, Castle PE, Schiffman M, Tokugawa D, Poitras N, Lorey T, Kinney W, Wentzensen N. JAMA Oncol; 2019 Feb 01; 5(2):181-186. PubMed ID: 30325982 [Abstract] [Full Text] [Related]
12. Triaging HPV-positive, cytology-negative cervical cancer screening results with extended HPV genotyping and p16INK4a immunostaining in China. Song F, Yan P, Huang X, Wang C, Qu X, Du H, Wu R. BMC Infect Dis; 2021 Apr 30; 21(1):400. PubMed ID: 33931022 [Abstract] [Full Text] [Related]
13. Triaging Pap cytology negative, HPV positive cervical cancer screening results with p16/Ki-67 Dual-stained cytology. Petry KU, Schmidt D, Scherbring S, Luyten A, Reinecke-Lüthge A, Bergeron C, Kommoss F, Löning T, Ordi J, Regauer S, Ridder R. Gynecol Oncol; 2011 Jun 01; 121(3):505-9. PubMed ID: 21420158 [Abstract] [Full Text] [Related]
14. p16/Ki-67 dual staining has a better accuracy than human papillomavirus (HPV) testing in women with abnormal cytology under 30 years old. Pirtea L, Secosan C, Margan M, Moleriu L, Balint O, Grigoras D, Sas I, Horhat F, Jianu A, Ilina R. Bosn J Basic Med Sci; 2019 Nov 08; 19(4):336-341. PubMed ID: 29924960 [Abstract] [Full Text] [Related]
15. Combined use of cytology, p16 immunostaining and genotyping for triage of women positive for high-risk human papillomavirus at primary screening. Cuzick J, Adcock R, Carozzi F, Gillio-Tos A, De Marco L, Del Mistro A, Frayle H, Girlando S, Sani C, Confortini M, Zorzi M, Giorgi-Rossi P, Rizzolo R, Ronco G, New Technologies for Cervical Cancer Screening Working Group. Int J Cancer; 2020 Oct 01; 147(7):1864-1873. PubMed ID: 32170961 [Abstract] [Full Text] [Related]
16. Evaluation of p16/Ki-67 dual-stained cytology as triage test for high-risk human papillomavirus-positive women. Ebisch RM, van der Horst J, Hermsen M, Rijstenberg LL, Vedder JE, Bulten J, Bosgraaf RP, Verhoef VM, Heideman DA, Snijders PJ, Meijer CJ, van Kemenade FJ, Massuger LF, Melchers WJ, Bekkers RL, Siebers AG. Mod Pathol; 2017 Jul 01; 30(7):1021-1031. PubMed ID: 28304400 [Abstract] [Full Text] [Related]
17. Clinical validation of p16/Ki-67 dual-stained cytology triage of HPV-positive women: Results from the IMPACT trial. Wright TC, Stoler MH, Ranger-Moore J, Fang Q, Volkir P, Safaeian M, Ridder R. Int J Cancer; 2022 Feb 01; 150(3):461-471. PubMed ID: 34536311 [Abstract] [Full Text] [Related]
18. Clinical Evaluation of Human Papillomavirus Screening With p16/Ki-67 Dual Stain Triage in a Large Organized Cervical Cancer Screening Program. Wentzensen N, Clarke MA, Bremer R, Poitras N, Tokugawa D, Goldhoff PE, Castle PE, Schiffman M, Kingery JD, Grewal KK, Locke A, Kinney W, Lorey TS. JAMA Intern Med; 2019 Jul 01; 179(7):881-888. PubMed ID: 31081870 [Abstract] [Full Text] [Related]
19. Clinical value of fully automated p16/Ki-67 dual staining in the triage of HPV-positive women in the Norwegian Cervical Cancer Screening Program. Ovestad IT, Dalen I, Hansen E, Loge JL, Dybdahl BM, Dirdal MB, Moltu P, Berland JM. Cancer Cytopathol; 2017 Apr 01; 125(4):283-291. PubMed ID: 27918650 [Abstract] [Full Text] [Related]
20. Optimization of HPV-positive women triage with p16/Ki67 dual staining cytology in an organized cervical cancer screening program in the center region of Portugal. Sepodes B, Rebelo T, Santos F, Oliveira D, Catalão C, Águas F, Fernandes G. Eur J Obstet Gynecol Reprod Biol; 2024 Nov 01; 302():111-115. PubMed ID: 39244854 [Abstract] [Full Text] [Related] Page: [Next] [New Search]